Works matching DE "PROSTATE-specific membrane antigen"

Results: 627

Improved OS is found in mCRPC after PSMA-targeted therapy.
Published in:
Urology Times, 2021, v. 49, n. 7, p. 16
By:
- MIAN, BADAR M.
Publication type:
Article
177Lu-PSMA-617 signi?cantly improves survival in metastatic CRPC: Bene? ts were also observed for objective response rate and disease control rate.
Published in:
Urology Times, 2021, v. 49, n. 7, p. 14
By:
- BRODERICK, JASON M.
Publication type:
Article
FROM THE CO-EDITOR IN CHIEF. PSMA, VISION, and the Will Rogers phenomenon.
Published in:
2021
By:
- COOKSON, MICHAEL S.
Publication type:
Editorial
UroPipeline. FDA authorizes trial of novel PSMA theranostics in metastatic CRPC.
Published in:
Urology Times, 2021, v. 49, n. 6, p. 10
By:
- BRODERICK, JASON M.
Publication type:
Article
PSMA theranostic 177Lu-PSMA-617 approaches prime time in mCRPC.
Published in:
Urology Times, 2021, v. 49, n. 5, p. 21
By:
- Broderick, Jason M.
Publication type:
Article
High-risk disease with oligometastasis.
Published in:
Urology Times, 2021, v. 49, n. 4, p. 1
Publication type:
Article
PSMA-targeting agents will change prostate cancer diagnostics and treatment.
Published in:
2021
Publication type:
Interview
Excitement grows for prostate cancer theranostics.
Published in:
Urology Times, 2021, v. 49, n. 3, p. 6
By:
- HENNESSY SR, MIKE
Publication type:
Article
Urologists target PSMA in prostate cancer: Multiple FDA approvals are anticipated in theranostics space.
Published in:
Urology Times, 2021, v. 49, n. 3, p. 1
By:
- Hilton, Lisette
Publication type:
Article
PSMA-targeted therapy well tolerated in men with mCRPC.
Published in:
Urology Times, 2020, v. 48, n. 2, p. 13
By:
- Schieszer, John
Publication type:
Article
Antibody-guided brachytherapy appears effective.
Published in:
Urology Times, 2003, v. 31, n. 12, p. 6
By:
- Tennant, Scott
Publication type:
Article
Early and repetitive novel-tracer PET-guided stereotactic body radiotherapy for nodal oligorecurrent prostate cancer after definitive first-line therapy.
Published in:
Strahlentherapie und Onkologie, 2025, v. 201, n. 1, p. 36, doi. 10.1007/s00066-024-02304-9
By:
- Grün, Arne;
- Cumaoglu, Selin;
- Kluge, Anne;
- Schlomm, Thorsten;
- Böhmer, Dirk;
- Miller, Kurt;
- Heidenreich, Holger;
- Zips, Daniel;
- Kalinauskaite, Goda
Publication type:
Article
(68)Ga-PSMA-PET/CT-basierte Strahlentherapie beim lokal rezidivierten und oligometastasierten Prostatakarzinom : Frühe Effektivität nach Primärtherapie.
Published in:
2016
By:
- Henkenberens, Christoph;
- von Klot, Christoph;
- Ross, Tobias;
- Bengel, Frank;
- Wester, Hans-Jürgen;
- Merseburger, Axel;
- Vogel-Claussen, Jens;
- Christiansen, Hans;
- Derlin, Thorsten;
- von Klot, Christoph A;
- Ross, Tobias L;
- Bengel, Frank M;
- Wester, Hans-Jürgen;
- Merseburger, Axel S
Publication type:
journal article
Fluorescent Conjugates Based on Prostate-Specific Membrane Antigen Ligands as an Effective Visualization Tool for Prostate Cancer.
Published in:
Biochemistry (00062979), 2023, v. 88, n. 7, p. 953, doi. 10.1134/S0006297923070088
By:
- Uspenskaia, Anastasiia A.;
- Krasnikov, Pavel A.;
- Beloglazkina, Elena K.;
- Machulkin, Aleksei E.
Publication type:
Article
Unexpected Metastatic Localization of Prostate Cancer Determined by Ga-68 PSMA PET/CT: Choroid.
Published in:
Türkiye Klinikleri Journal of Case Reports, 2022, v. 30, n. 2, p. 102, doi. 10.5336/caserep.2021-86462
By:
- MÜTEVELİZADE, Gözde;
- SEZGİN, Ceren;
- GÜMÜŞER, Gül;
- SAYIT, Elvan
Publication type:
Article
The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors.
Published in:
Turkish Archives of Otorhinolaryngology, 2022, v. 60, n. 4, p. 206, doi. 10.4274/tao.2022.2022-12-3
By:
- Sivrice, Mehmet Emre;
- Yasan, Hasan;
- Kumbul, Yusuf Çağdaş;
- Ertunç, Onur;
- Sayın, Sarper
Publication type:
Article
In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
Published in:
Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 1, p. 36, doi. 10.1038/sj.pcan.4500543
By:
- Li, Y.;
- Tian, Z.;
- Rizvi, S. M. A.;
- Bander, N. H.;
- Allen, B. J.
Publication type:
Article
Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene.
Published in:
Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 4, p. 180, doi. 10.1038/sj.pcan.4500325
By:
- Maraj, B H;
- Markham, A F
Publication type:
Article
68Ga--Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma.
Published in:
Asia Oceania Journal of Nuclear Medicine & Biology, 2020, v. 8, n. 2, p. 136, doi. 10.22038/AOJNMB.2020.46939.1314
By:
- Chahinian, Rita;
- El-Amine, Ahmad;
- Matar, Sayed;
- Annan, Mostafa;
- Shamseddine, Ali;
- Haidar, Mohamad
Publication type:
Article
Challenges in the solution phase synthesis of PSMA-11 and PSMA-617: organic ligands for radiopharmaceutical preparations in prostate cancer medication.
Published in:
Radiochimica Acta, 2024, v. 112, n. 9, p. 651, doi. 10.1515/ract-2024-0280
By:
- Kumar, K. S. Ajish;
- Mathur, Anupam
Publication type:
Article
Editorial Comment to Positron emission tomography/magnetic resonance imaging with 68 Gallium-labeled ligand of prostate-specific membrane antigen: Promising novel option in prostate cancer imaging?
Published in:
International Journal of Urology, 2014, v. 21, n. 12, p. 1288, doi. 10.1111/iju.12596
By:
- Wetter, Axel
Publication type:
Article
Aptamers as Theragnostic Tools in Prostate Cancer.
Published in:
Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1056, doi. 10.3390/biom12081056
By:
- Cruz-Hernández, Carlos David;
- Rodríguez-Martínez, Griselda;
- Cortés-Ramírez, Sergio A.;
- Morales-Pacheco, Miguel;
- Cruz-Burgos, Marian;
- Losada-García, Alberto;
- Reyes-Grajeda, Juan Pablo;
- González-Ramírez, Imelda;
- González-Covarrubias, Vanessa;
- Camacho-Arroyo, Ignacio;
- Cerbón, Marco;
- Rodríguez-Dorantes, Mauricio
Publication type:
Article
Current status of PSMA-targeted imaging and therapy.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2023.1230251
By:
- Hui Wang;
- GuanNan Li;
- Jie Zhao;
- Eiber, Matthias;
- Rong Tian
Publication type:
Article
177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry.
Published in:
Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1221103
By:
- Abouzayed, Ayman;
- Seitova, Kamila;
- Lundmark, Fanny;
- Bodenko, Vitalina;
- Oroujeni, Maryam;
- Tolmachev, Vladimir;
- Rosenström, Ulrika;
- Orlova, Anna
Publication type:
Article
Preclinical comparison of four [18F, natGa]rhPSMA-7 isomers: influence of the stereoconfiguration on pharmacokinetics.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00740-z
By:
- Wurzer, Alexander;
- Parzinger, Mara;
- Konrad, Matthias;
- Beck, Roswitha;
- Günther, Thomas;
- Felber, Veronika;
- Färber, Stefanie;
- Di Carlo, Daniel;
- Wester, Hans-Jürgen
Publication type:
Article
Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13550-020-00720-3
By:
- Lawhn-Heath, Courtney;
- Yom, Sue S.;
- Liu, Chienying;
- Villanueva-Meyer, Javier E.;
- Aslam, Maya;
- Smith, Raven;
- Narwal, Manpreet;
- Juarez, Roxanna;
- Behr, Spencer C.;
- Pampaloni, Miguel Hernandez;
- Chan, Jason W.;
- Glastonbury, Christine M.;
- Hope, Thomas A.;
- Flavell, Robert R.
Publication type:
Article
Voxel-based comparison of [68Ga]Ga-RM2-PET/CT and [68Ga]Ga-PSMA-11-PET/CT with histopathology for diagnosis of primary prostate cancer.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00652-y
By:
- Fassbender, Thomas Franz;
- Schiller, Florian;
- Zamboglou, Constantinos;
- Drendel, Vanessa;
- Kiefer, Selina;
- Jilg, Cordula A.;
- Grosu, Anca-Ligia;
- Mix, Michael
Publication type:
Article
[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center.
Published in:
EJNMMI Research, 2020, v. 10, n. 1, p. 1, doi. 10.1186/s13550-020-00635-z
By:
- Werner, P.;
- Neumann, C.;
- Eiber, M.;
- Wester, H. J.;
- Schottelius, M.
Publication type:
Article
Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples.
Published in:
EJNMMI Research, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13550-019-0517-6
By:
- Schollhammer, Romain;
- De Clermont Gallerande, Henri;
- Yacoub, Mokrane;
- Quintyn Ranty, Marie-Laure;
- Barthe, Nicole;
- Vimont, Delphine;
- Hindié, Elif;
- Fernandez, Philippe;
- Morgat, Clément
Publication type:
Article
Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity.
Published in:
EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0440-2
By:
- Wirtz, Martina;
- Schmidt, Alexander;
- Schottelius, Margret;
- Robu, Stephanie;
- Günther, Thomas;
- Wester, Hans-Jürgen;
- Schwaiger, Markus
Publication type:
Article
Prostate-specific antigen: current status.
Published in:
1999
By:
- Brawer, Michael K.;
- Brawer, M K
Publication type:
journal article
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer.
Published in:
Acta Oncologica, 2024, v. 63, n. 1, p. 503, doi. 10.2340/1651-226X.2024.39041
By:
- Zarei, Maryam;
- Wallsten, Elin;
- Grefve, Josefine;
- Söderkvist, Karin;
- Gunnlaugsson, Adalsteinn;
- Sandgren, Kristina;
- Jonsson, Joakim;
- Lindberg, Angsana Keeratijarut;
- Nilsson, Erik;
- Bergh, Anders;
- Zackrisson, Björn;
- Moreau, Mathieu;
- Karlsson, Camilla Thellenberg;
- Olsson, Lars. E.;
- Widmark, Anders;
- Riklund, Katrine;
- Blomqvist, Lennart;
- Loegager, Vibeke Berg;
- Axelsson, Jan;
- Strandberg, Sara N.
Publication type:
Article
Is there a role for repeating PSMA PET/CT after a negative scan in biochemical recurrent prostate cancer?
Published in:
2020
By:
- Mjaess, Georges;
- Vierasu, Irina;
- Lacroix, Simon;
- Aoun, Fouad;
- Goldman, Serge;
- Roumeguère, Thierry;
- Albisinni, Simone
Publication type:
Letter
68Ga-PSMA-PET/CT-directed IGRT/SBRT for oligometastases of recurrent prostate cancer after initial surgery.
Published in:
Acta Oncologica, 2020, v. 59, n. 2, p. 149, doi. 10.1080/0284186X.2019.1669816
By:
- Marzec, J.;
- Becker, J.;
- Paulsen, F.;
- Wegener, D.;
- Olthof, S.-C.;
- Pfannenberg, C.;
- Schwenck, J.;
- Bedke, J.;
- Stenzl, A.;
- Nikolaou, K.;
- la Fougère, C.;
- Zips, D.;
- Müller, A.-C.
Publication type:
Article
Novel and Efficient Method for Solid Phase Synthesis of Urea-Containing Peptides Targeting Prostate Specific Membrane Antigen (PSMA) in Comparison with Current Methods.
Published in:
Iranian Journal of Pharmaceutical Research, 2018, v. 17, n. 3, p. 917
By:
- Mosayebnia, Mona;
- Rezaeianpour, Sedigheh;
- Rikhtechi, Pedram;
- Hajimahdi, Zahra;
- Beiki, Davood;
- Kobarfard, Farzad;
- sabzevari, Omid;
- Amini, Mohsen;
- Abdi, Khosrou;
- Shahhosseini, Soraya
Publication type:
Article
PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
Published in:
Science Signaling, 2017, v. 10, n. 470, p. 1, doi. 10.1126/scisignal.aag3326
By:
- Caromile, Leslie Ann;
- Dortche, Kristina;
- Mamunur Rahman, M.;
- Grant, Christina L.;
- Stoddard, Christopher;
- Ferrer, Fernando A.;
- Shapiro, Linda H.
Publication type:
Article
Patterns of failure with 18F-DCFPyL PSMA-PET/CT in the post-prostatectomy setting A regional cohort analysis.
Published in:
Canadian Urological Association Journal, 2025, v. 19, n. 2, p. 17, doi. 10.5489/cuaj.8859
By:
- Sigurdson, Samantha;
- al Salman, Khalid;
- Mesci, Aruz;
- Dayes, Ian;
- Quan, Kimmen;
- Goldberg, Mira;
- Schnarr, Kara;
- Shayegan, Bobby;
- Bauman, Glenn;
- Zukotynski, Katherine;
- Tsakiridis, Theodoros;
- Lukka, Himu
Publication type:
Article
PSMA-PET in Canada: More questions than answers.
Published in:
Canadian Urological Association Journal, 2023, v. 17, n. 8, p. 254, doi. 10.5489/cuaj.8490
By:
- Morris, Heather;
- Lavallée, Luke T.
Publication type:
Article
18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study.
Published in:
Canadian Urological Association Journal, 2023, v. 17, n. 8, p. 247, doi. 10.5489/cuaj.8165
By:
- Arifin, Andrew J.;
- Gulstene, Stephanie;
- Warner, Andrew;
- Bauman, Glenn S.;
- Mendez, Lucas C.
Publication type:
Article
Adding prostate-specific membrane antigen positron emission tomography (PSMA PET) to our prostate cancer armamentarium raises many questions.
Published in:
Canadian Urological Association Journal, 2021, v. 15, n. 6, p. 179, doi. 10.5489/cuaj.7336
By:
- Klotz, Laurence
Publication type:
Article
18F-fluorocholine positron emission tomography-computed tomography (18F-FCH PET/CT) for staging of high-risk prostate cancer patients.
Published in:
Canadian Urological Association Journal, 2019, v. 13, n. 4, p. 84, doi. 10.5489/cuaj.5142
By:
- Gauvin, Simon;
- Rompré-Brodeur, Alexis;
- Chaussé, Guillaume;
- Anidjar, Maurice;
- Bladou, Franck;
- Probst, Stephan
Publication type:
Article
In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model.
Published in:
Journal of Nanotechnology, 2017, p. 1, doi. 10.1155/2017/8424686
By:
- Abraham, Christopher Brian;
- Jani, Prashant;
- Turuba, Roxanne;
- Campbell, Michael;
- Zehbe, Ingeborg;
- Curiel, Laura
Publication type:
Article
Optimal use, combinations, and sequencing of therapies in advanced prostate cancer.
Published in:
Expert Review of Clinical Pharmacology, 2025, v. 18, n. 1/2, p. 13, doi. 10.1080/17512433.2025.2451643
By:
- Oakley, Clayton K.;
- Teply, Benjamin A.
Publication type:
Article
Radiation Oncology Orals.
Published in:
Journal of Medical Imaging & Radiation Oncology, 2024, v. 68, p. 185, doi. 10.1111/1754-9485.13780
Publication type:
Article
Utility of Ga68 prostate-specific membrane antigen positron-emission tomography for pre-operative staging of high-risk prostate cancer in a prospective cohort.
Published in:
2020
By:
- Tarr, Gregory Patrick;
- Kashyap, Puja;
- Dixit, Devesh Datta;
- Willams, Andrew Keith;
- Koya, Madhusudhan Prasad;
- Lim, Remy
Publication type:
journal article
Lu177-PSMA therapy for men with advanced prostate cancer: Initial 18 months experience at a single Australian tertiary institution.
Published in:
2019
By:
- McBean, Rhiannon;
- O'Kane, Brooke;
- Parsons, Rex;
- Wong, David
Publication type:
journal article
Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre.
Published in:
2019
By:
- Haran, Crishan;
- McBean, Rhiannon;
- Parsons, Rex;
- Wong, David
Publication type:
journal article
Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography/CT and diagnostic CT scan in primary staging for prostate cancer.
Published in:
2019
By:
- McEwan, Louise;
- McBean, Rhiannon;
- Wong, David;
- Yaxley, John
Publication type:
journal article
Gallium-68 PSMA uptake in adrenal adenoma.
Published in:
2016
By:
- Law, W Phillip;
- Fiumara, Frank;
- Fong, William;
- Miles, Kenneth A
Publication type:
journal article
Molecular therapy of prostate carcinoma.
Published in:
Archive of Oncology, 2012, v. 20, n. 3/4, p. 149, doi. 10.2298/AOO1204149G
By:
- Goldsmith, Stanley J.
Publication type:
Article